TICKERNERD
Menu
SNESSNESBasic Materials · Specialty Chemicals

SNES Stock Forecast: SenesTech, Inc. Price Predictions for 2026-2027

Last close, 3 Aug 2026
$1.55
+14.81% on the day

The 1 Wall Street analysts covering SenesTech, Inc. hold a median 12-month price target of $6.75 — +335.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 8 of 100 as at 1 Aug 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$7.2M
Ticker Nerd rank
8 / 100
Median analyst target
$6.75
Analysts covering
1
Total return, dividends reinvested
1W
+16.5%
1M
+4.0%
YTD
−27.6%
1Y
−70.5%
From 52W high
−74.8%
From 52W low
+22.0%
$1.27
$6.15
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

SNES stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores SenesTech, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
8 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
94
Quality
40
Revisions
33
Growth
31
Accruals
23
Volatility
16
Momentum
12
Value
10
Issuance
4

Size (94): Smaller than most of the companies we track.

Issuance (4): The company has been issuing shares or taking on financing, diluting existing holders.

The rank is the raw material. Whether the rules would actually own SenesTech, Inc. — and when they’d sell — is the membership.

Wall Street

SNES stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on SNES, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.00$2.00$4.00$6.00$8.00$10.00Oct 25Jan 26Apr 26Jul 26SNESHigh $10.00Median $6.75Low $3.50

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says1 analysts
1 Buy0 Hold0 Sell
Low $3.50Median $6.75High $10.00

The green dot is the last close — the median target sits +335.5% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
13 Dec 2024HC Wainwright & Co.ReiteratesBuy$3.50 → $10
12 Dec 2024HC Wainwright & Co.MaintainsBuy$3.50 → $10
14 May 2024HC Wainwright & Co.ReiteratesBuy—
28 Dec 2023HC Wainwright & Co.MaintainsBuy—
24 May 2023HC Wainwright & Co.ReiteratesBuy$4.00
18 Apr 2023HC Wainwright & Co.ReiteratesBuy$4.00
20 Jan 2021HC Wainwright & Co.InitiatesBuy$4.00
25 Nov 2020Craig-HallumInitiatesBuy—
4 Jan 2017Craig-HallumInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

SNES analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
1
Fundamentals

SenesTech, Inc. (SNES) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
0.0×

Cheaper than 73% of US stocks

Price / sales
3.2×

Cheaper than 39% of US stocks

Price / book
0.9×

Cheaper than 74% of US stocks

EV / EBITDA
−0.4×

Cheaper than 64% of US stocks

Growth & margins
Revenue growth (YoY)
1.6%

Higher than 33% of US stocks

Earnings growth (YoY)
1.6%

Higher than 39% of US stocks

Gross margin
68.6%

Higher than 82% of US stocks

Operating margin
−429.8%

Higher than 8% of US stocks

Net margin
62.5%

Higher than 97% of US stocks

Returns & dividend
Return on equity
−128.0%

Higher than 11% of US stocks

Return on assets
−59.2%

Higher than 6% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

SNES vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Chemicals
CompanyMarket capTKN rank
SNESSenesTech, Inc.$7.2M
8
YMATJ-Star Holding Co., Ltd.$7.5M
11
BONBon Natural Life Ltd.$8.9M
11
CNEYCN Energy Group, Inc.$4.6M
24
BGLCBioNexus Gene Lab Corp.$3.2M
12
LOOPLoop Industries, Inc.$34.8M
14
FEAM5E Advanced Materials, Inc.$45.7M
27
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SNES appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest SNES news & analysis

SenesTech Active Subscriber Base More Than Doubles as E-commerce Strategy Gains Momentum

PRNewsWire · 3 Aug 2026positive

SenesTech reported that its active subscriber base more than doubled, attributing the growth to its integrated e-commerce strategy. The company said the strategy is driving recurring revenue and supporting long-term growth across consumer and business-to-business markets.

Why it matters — A SNES watcher would care because subscriber growth and recurring revenue from e-commerce suggest expanding demand across both consumer and B2B channels.

SenesTech to Report Second Quarter 2026 Financial Results on Wednesday, August 5, 2026

PRNewsWire · 29 July 2026neutral

SenesTech announced it will report its second quarter 2026 financial results after market close on Wednesday, August 5, 2026, followed by a conference call at 5:00 p.m. Eastern time.

Why it matters — The earnings release and conference call will provide SNES investors with the company's latest financial performance and operational updates.

FAQ

Frequently asked questions about SNES stock

What is the SNES stock price forecast for 2026-2027?

The 1 Wall Street analysts covering SenesTech, Inc. have a median 12-month price target of $6.75, with estimates ranging from $3.5 to $10. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is SNES stock a buy right now?

Of the 1 analysts covering SenesTech, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks SenesTech, Inc. 8 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank SNES?

As at 1 Aug 2026, SenesTech, Inc. ranks 8 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (94 of 100).

Will SNES stock go up?

No one can know that. What the data says: the median 12-month target from 1 analysts implies +335.5% from the last close, and Ticker Nerd's factor model ranks SenesTech, Inc. 8 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the SNES stock forecast for 2030?

No analyst covering SenesTech, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SNES are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $3.5 to $10 over the next 12 months.

How has SNES stock performed over the past year?

SenesTech, Inc. returned -70.5% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does SenesTech, Inc. do?

SenesTech Inc. is a biotechnology company specializing in the development and commercialization of fertility control technologies for humane management of animal pest populations, particularly rodents.

What is the latest news on SNES?

The most recent item we track (PRNewsWire, 3 Aug 2026): "SenesTech Active Subscriber Base More Than Doubles as E-commerce Strategy Gains Momentum". SenesTech reported that its active subscriber base more than doubled, attributing the growth to its integrated e-commerce strategy. The company said the strategy is driving recurring revenue and supporting long-term growth across consumer and business-to-business markets.

Company

About SenesTech, Inc.

SenesTech Inc. is a biotechnology company specializing in the development and commercialization of fertility control technologies for humane management of animal pest populations, particularly rodents. Its primary products include ContraPest, a liquid bait with active ingredients 4-vinylcyclohexene diepoxide and triptolide that serves as the only U.S. EPA-registered contraceptive for both male and female rats, and Evolve, a soft bait featuring cottonseed oil that limits reproduction in rats from the first breeding cycles after consumption. The company also offers Evolve Mouse, an adapted version targeting male and female mice after one to two breeding cycles. These products integrate into comprehensive integrated pest management programs, providing non-lethal alternatives to traditional rodenticides for urban, commercial, warehousing, and municipal applications. SenesTech Inc. supports global distribution efforts, including partnerships in regions like Indonesia, New Zealand, Belize, and Australia, alongside direct-to-consumer e-commerce channels such as Amazon. Additionally, it provides teleconsulting and technical advisory services to optimize pest control strategies. Founded in 2004 and headquartered in Phoenix, Arizona, SenesTech Inc. focuses on sustainable, environmentally friendly solutions for pest management across residential, business, and public sectors.

CEO Mr. Michael Edell · 23 employees · United States · https://www.senestech.com